Skip to main content
SpringerLink
Log in

Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?

  • Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer (N Kubiliun, Section Editor)
  • Published:
Current Colorectal Cancer Reports

Abstract

Purpose of Review

Up to 50% of patients with stage II or III colon cancer are estimated to develop locoregional recurrence, distant metastasis, or metachronous colon cancers within 5 years of initial treatment. Given the high risk of recurrence, surveillance is critical, but what is the optimal frequency and testing of surveillance, and is it possible to tailor surveillance plans based on risk prediction tools?

Recent Findings

We reviewed the current national guidelines from 6 reputable oncologic organizations, as well as 10 randomized controlled trials and numerous meta-analyses in the last 22 years evaluating more intensive to less intensive surveillance to answer this question. Currently available adjunct testing, such as genomic testing, and risk calculators were also evaluated.

Summary

Overall, high-frequency surveillance, to a limit, has been established as superior to less frequency surveillance. Future research will likely demonstrate evidence for adjunct testing for personalized surveillance screening based on individual recurrence risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017 Jan;67(1):7–30. doi:10.3322/caac.21387.

    Article  PubMed  Google Scholar 

  2. Abulafi AM, Williams NS. Local recurrence of colorectal cancer: the problem, mechanisms, management and adjuvant therapy. Br J Surg. 1994 Jan;81(1):7–19. Review

  3. Devesa JM, Morales V, Enriquez JM, Nuño J, Camuñas J, Hernandez MJ, et al. Colorectal cancer. The bases for a comprehensive follow-up. Dis Colon Rectum. 1988 Aug;31(8):636–52. Review

  4. Obrand DI, Gordon PH. Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum. 1997 Jan;40(1):15–24.

    Article  CAS  PubMed  Google Scholar 

  5. Ryuk JP, Choi GS, Park JS, Kim HJ, Park SY, Yoon GS, et al. Predictive factors and the prognosis of recurrence of colorectal cancer within 2 years after curative resection. Ann Surg Treat Res. 2014 Mar;86(3):143–51. doi:10.4174/astr.2014.86.3.143.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, et al. 3rd; American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013 Dec 10;31(35):4465–70. doi:10.1200/JCO.2013.50.7442.

    Article  PubMed  Google Scholar 

  7. National Comprehensive Cancer Network. Guidelines for treatment of colorectal cancer. NCCN. https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site (2017).

  8. Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A, ESMO Guidelines Working Group. Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up. Ann Oncol. 2010 May;21 Suppl 5:v70-7. doi: 10.1093/annonc/mdq168.

  9. Labianca R, Nordlinger B, Beretta GD, Mosconi S, Mandalà M, Cervantes A, Arnold D, ESMO Guidelines Working Group. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24 Suppl 6:vi64-72. doi: 10.1093/annonc/mdt354.

  10. El-Shami K, Oeffinger KC, Erb NL, Willis A, Bretsch JK, Pratt-Chapman ML, et al. American Cancer Society colorectal cancer survivorship care guidelines. CA Cancer J Clin. 2015 Nov-Dec;65(6):428–55. doi:10.3322/caac.21286. Epub 2015 Sep 8

  11. American Gastroenterology Association. AGA institute guidelines for colonoscopy surveillance after cancer resection: clinical decision tool. Gastroenterology. 2014 May;146(5):1413–4. doi:10.1053/j.gastro.2014.03.029.

    Article  Google Scholar 

  12. Steele SR, Chang GJ, Hendren S, Weiser M, Irani J, Buie WD, et al. Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. Practice guideline for the surveillance of patients after curative treatment of colon and rectal cancer. Dis Colon Rectum. 2015 Aug;58(8):713–25. doi:10.1097/DCR.0000000000000410. Review

  13. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R, Zuraw L, Zwaal C. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care. BMC Cancer. 2003 Oct 6;3:26.

  14. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ. 2002 Apr 6;324(7341):813. Review

  15. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon rectum. 2007 Nov;50(11):1783–99. Review

  16. Jeffery M, Hickey BE, Hider PN, See AM. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2016 Nov 24;11:CD002200. Review

  17. Mäkelä JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg. 1995 Oct;130(10):1062–7.

    Article  PubMed  Google Scholar 

  18. Ohlsson B, Breland U, Ekberg H, Graffner H, Tranberg KG. Follow-up after curative surgery for colorectal carcinoma. Randomized comparison with no follow-up. Dis Colon Rectum. 1995 Jun;38(6):619–26.

    Article  CAS  PubMed  Google Scholar 

  19. Kjeldsen BJ, Kronborg O, Fenger C, Jørgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997 May;84(5):666–9.

    Article  CAS  PubMed  Google Scholar 

  20. Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon rectum. 1998 Sep;41(9):1127–33.

  21. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology. 1998 Jan;114(1):7–14.

    Article  CAS  PubMed  Google Scholar 

  22. Secco GB, Fardelli R, Gianquinto D, Bonfante P, Baldi E, Ravera G, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002 Jun;28(4):418–23.

    Article  PubMed  Google Scholar 

  23. Rodríguez-Moranta F, Saló J, Arcusa A, Boadas J, Piñol V, Bessa X, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006 Jan 20;24(3):386–93.

    Article  PubMed  Google Scholar 

  24. Wang T, Cui Y, Huang WS, Deng YH, Gong W, Li CJ, et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. Gastrointest Endosc. 2009 Mar;69(3 Pt 2):609–15. doi:10.1016/j.gie.2008.05.017.

    Article  PubMed  Google Scholar 

  25. • Primrose JN, Perera R, Gray A, Rose P, Fuller A, Corkhill A, George S, Mant D; FACS Trial Investigators. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA. 2014 Jan 15;311(3):263-70. doi: 10.1001/jama.2013.285718. Randomized controlled trial comparing survival benefit of intensive screening with CEA, CT, CEA and CT, and minimal follow-up; demonstrated increased rate of surgical treatment for recurrence, however did not show statistically significant survival advantage.

  26. • Rosati G, Ambrosini G, Barni S, Andreoni B, Corradini G, Luchena G, Daniele B, Gaion F, Oliverio G, Duro M, Martignoni G, Pinna N, Sozzi P, Pancera G, Solina G, Pavia G, Pignata S, Johnson F, Labianca R, Apolone G, Zaniboni A, Monteforte M, Negri E, Torri V, Mosconi P, Fossati R; GILDA working group. A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma. Ann Oncol. 2016 Feb;27(2):274–80. doi: 10.1093/annonc/mdv541. Randomized trial comparing increased frequency of colonoscopy and imaging after colorectal cancer treatment; follow-up frequency was the same. Demonstrated higher surgical treatment with curative intent, but no significant survival advantage.

  27. Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol. 2004 Aug-Nov;13(2–3):119–24.

    Article  PubMed  Google Scholar 

  28. Augestad KM, Norum J, Dehof S, Aspevik R, Ringberg U, Nestvold T, Vonen B, Skrøvseth SO, Lindsetmo RO. Cost-effectiveness and quality of life in surgeon versus general practitioner-organised colon cancer surveillance: a randomised controlled trial. BMJ Open. 2013 Apr 4;3(4). pii: e002391. doi: 10.1136/bmjopen-2012-002391. Print 2013.

  29. Strand E, Nygren I, Bergkvist L, Smedh K. Nurse or surgeon follow-up after rectal cancer: a randomized trial. Color Dis. 2011 Sep;13(9):999–1003. doi:10.1111/j.1463-1318.2010.02317.x.

    Article  CAS  Google Scholar 

  30. Wattchow DA, Weller DP, Esterman A, Pilotto LS, McGorm K, Hammett Z, Platell C, Silagy C. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer. 2006 Apr 24;94(8):1116-21.

  31. Treasure T, Monson K, Fiorentino F, Russell C. The CEA second-look trial: a randomised controlled trial of carcinoembryonic antigen prompted reoperation for recurrent colorectal cancer. BMJ Open. 2014 May 13;4(5):e004385. doi:10.1136/bmjopen-2013-004385.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Hansdotter Andersson P, Wille-Jørgensen P, Horváth-Puhó E, Petersen SH, Martling A, Sørensen HT, et al. The COLOFOL trial: study design and comparison of the study population with the source cancer population. Clin Epidemiol. 2016 Jan 28;8:15–21. doi:10.2147/CLEP.S92661. eCollection 2016

  33. Mokhles S, Macbeth F, Farewell V, Fiorentino F, Williams NR, Younes RN, et al. Meta-analysis of colorectal cancer follow-up after potentially curative resection. Br J Surg. 2016 Sep;103(10):1259–68. doi:10.1002/bjs.10233. Epub 2016 Aug 4

  34. •• Pita-Fernández S, Alhayek-Aí M, González-Martín C, López-Calviño B, Seoane-Pillado T, Pértega-Díaz S. Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: a systematic review and meta-analysis. Ann Oncol. 2015 Apr;26(4):644–56. doi: 10.1093/annonc/mdu543. Epub 2014 Nov 19. Systematic review and meta-analysis demonstrating improved outcomes in colorectal cancer patients with intensive follow-up strategies.

  35. •• Van der Stok EP, Spaander MC, Grünhagen DJ, Verhoef C, Kuipers EJ. Surveillance after curative treatment for colorectal cancer. Nat Rev Clin Oncol. 2016 Dec 20. Ddoi: 10.1038/nrclinonc.2016.199. Review article with pooled analysis which demonstrated overall survival benefit of intensive surveillance after colorectal cancer treatment.

  36. Guyot F, Faivre J, Manfredi S, Meny B, Bonithon-Kopp C, Bouvier AM. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005 May;16(5):756–61. Epub 2005 Mar 24

  37. Goldberg RM, Fleming TR, Tangen CM, Moertel CG, Macdonald JS, Haller DG, et al. Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med. 1998 Jul 1;129(1):27–35.

    Article  CAS  PubMed  Google Scholar 

  38. Staab HJ, Anderer FA, Stumpf E, Fischer R. Carcinoembryonic antigen follow-up and selection of patients for second-look operation in management of gastrointestinal carcinoma. J Surg Oncol. 1978;10(3):273–82.

    Article  CAS  PubMed  Google Scholar 

  39. Renehan AG, O'Dwyer ST, Whynes DK. Cost effectiveness analysis of intensive versus conventional follow up after curative resection for colorectal cancer. BMJ. 2004 Jan 10;328(7431):81.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Arnaud JP, Koehl C, Adloff M. Carcinoembryonic antigen (CEA) in diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum. 1980 Apr;23(3):141–4.

    Article  CAS  PubMed  Google Scholar 

  41. Steele G Jr, Ravikumar TS. Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg. 1989 Aug;210(2):127–38. Review

  42. Floriani I, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, et al. Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging. 2010 Jan;31(1):19–31. doi:10.1002/jmri.22010. Review

  43. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, et al., American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol. 2005 Nov 20;23(33):8512–9. Epub 2005 Oct 31

  44. Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. Pfister DG, Benson AB 3rd, Somerfield MR. N Engl J Med. 2004 Jun 3;350(23):2375-82. Review. No abstract available.

  45. Patel K, Hadar N, Lee J, Siegel BA, Hillner BE, Lau J. The lack of evidence for PET or PET/CT surveillance of patients with treated lymphoma, colorectal cancer, and head and neck cancer: a systematic review. J Nucl Med. 2013 Sep;54(9):1518–27. doi:10.2967/jnumed.112.119362.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Seo SI, Lim SB, Yoon YS, Kim CW, Yu CS, Kim TW, et al. Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients. J Surg Oncol. 2013 Jul;108(1):9–13. doi:10.1002/jso.23349. Epub 2013 Jun 10

  47. Lepage C, Phelip JM, Cany L, Faroux R, Manfredi S, Ain JF, et al. Effect of 5 years of imaging and CEA follow-up to detect recurrence of colorectal cancer: the FFCD PRODIGE 13 randomised phase III trial. Dig Liver Dis. 2015 Jul;47(7):529–31. doi:10.1016/j.dld.2015.03.021. Epub 2015 Apr 2

  48. Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK; United States Multi-Society Task Force on Colorectal Cancer. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2016 Mar;150(3):758-768.e11. doi: 10.1053/j.gastro.2016.01.001. Review.

  49. Green RJ, Metlay JP, Propert K, Catalano PJ, Macdonald JS, Mayer RJ, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of intergroup 0089. Ann Intern Med. 2002 Feb 19;136(4):261–9.

    Article  CAS  PubMed  Google Scholar 

  50. Samadder NJ, Curtin K, Wong J, Tuohy TM, Mineau GP, Smith KR, Pimentel R, Pappas L, Boucher K, Garrido-Laguna I, Provenzale D, Burt RW. Epidemiology and familial risk of synchronous and metachronous colorectal cancer: a population-based study in Utah. Clin Gastroenterol Hepatol. 2014 Dec;12(12):2078-84.e1-2. doi: 10.1016/j.cgh.2014.04.017.

  51. Das A, Chak A, Cooper GS. Temporal trend in relative risk of second primary colorectal cancer. Am J Gastroenterol. 2006 Jun;101(6):1342–7.

    Article  PubMed  Google Scholar 

  52. Augestad KM, Rose J, Crawshaw B, Cooper G, Delaney C. Do the benefits outweigh the side effects of colorectal cancer surveillance? A systematic review. World J Gastrointest Oncol. 2014 May 15;6(5):104–11. doi:10.4251/wjgo.v6.i5.104. Review

  53. Gill S, Loprinzi CL, Sargent DJ, Thomé SD, Alberts SR, Haller DG, et al. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004 May 15;22(10):1797–806. Epub 2004 Apr 5

  54. Renfro LA, Grothey A, Xue Y, Saltz LB, André T, Twelves C, Labianca R, Allegra CJ, Alberts SR, Loprinzi CL, Yothers G, Sargent DJ; Adjuvant Colon Cancer Endpoints (ACCENT) Group. ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer. J Natl Cancer Inst. 2014 Oct 29;106(12). pii: dju333. doi: 10.1093/jnci/dju333. Print 2014 Dec.

  55. Gray RG, Quirke P, Handley K, Lopatin M, Magill L, Baehner FL, et al. Validation study of a quantitative multigene reverse transcriptase-polymerase chain reaction assay for assessment of recurrence risk in patients with stage II colon cancer. J Clin Oncol. 2011 Dec 10;29(35):4611–9. doi:10.1200/JCO.2010.32.8732. Epub 2011 Nov 7

  56. Recent advances in personalized colorectal cancer research. Kraus S, Nabiochtchikov I, Shapira S, Arber N. Cancer Lett. 2014 May 28;347(1):15–21. doi: 10.1016/j.canlet.2014.01.025. Review.

  57. Goldstein TC, Paull EO, Ellis MJ, Stuart JM. Molecular pathways: extracting medical knowledge from high-throughput genomic data. Clin Cancer Res. 2013 Jun 15;19(12):3114–20. doi:10.1158/1078-0432.CCR-12-2093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, et al. Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol. 2011 Jan 1;29(1):17–24. doi:10.1200/JCO.2010.30.1077. Epub 2010 Nov 22

  59. Kopetz S, Tabernero J, Rosenberg R, Jiang ZQ, Moreno V, Bachleitner-Hofmann T, et al. Genomic classifier ColoPrint predicts recurrence in stage II colorectal cancer patients more accurately than clinical factors. Oncologist. 2015 Feb;20(2):127–33. doi:10.1634/theoncologist.2014-0325. Epub 2015 Jan 5

  60. Maak M, Simon I, Nitsche U, Roepman P, Snel M, Glas AM, et al. Independent validation of a prognostic genomic signature (ColoPrint) for patients with stage II colon cancer. Ann Surg. 2013 Jun;257(6):1053–8. doi:10.1097/SLA.0b013e31827c1180.

    Article  PubMed  Google Scholar 

  61. Lin HH, Wei NC, Chou TY, Lin CC, Lan YT, Chang SC, Wang HS, Yang SH, Chen WS, Lin TC, Lin JK, Jiang JK. Building personalized treatment plans for early-stage colorectal cancer patients. Oncotarget. 2017 Jan 13. doi: 10.18632/oncotarget.14638. [Epub ahead of print].

Download references

Author information

Authors and Affiliations

  1. Walter Reed National Military Medical Center, 8901 Wisconsin Ave, Bethesda, MD, 20889, USA

    Michele M. Gage & Matthew T. Hueman

Authors
  1. Michele M. Gage
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew T. Hueman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew T. Hueman.

Ethics declarations

Conflict of Interest

Michele M. Gage and Matthew T. Hueman declare they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Genetic Syndromes, Screening, and Surveillance in Colorectal Cancer

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gage, M.M., Hueman, M.T. Colorectal Cancer Surveillance: What Is the Optimal Frequency of Follow-up and Which Tools Best Predict Recurrence?. Curr Colorectal Cancer Rep 13, 316–324 (2017). https://doi.org/10.1007/s11888-017-0382-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11888-017-0382-5

Keywords

Search

Navigation